A Stable Parenteral Dosage Form Of Cetrorelix Acetate

Patent No. EP3811927 (titled "A Stable Parenteral Dosage Form Of Cetrorelix Acetate") was filed by SUN Pharmaceutical Industries on Mar 10, 2020. The application was issued on Feb 23, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
WEICKMANN & WEICKMANNAug 12, 2022-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3811927

SUN PHARMACEUTICAL INDUSTRIES
Application Number
EP20162018A
Filing Date
Mar 10, 2020
Status
Granted And Under Opposition
Oct 15, 2021
Publication Date
Feb 23, 2022